Versant Capital Management, Inc Apellis Pharmaceuticals, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 604 shares of APLS stock, worth $12,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
604
Previous 166
263.86%
Holding current value
$12,013
Previous $4,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
289Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$245 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$243 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$237 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$201 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$191 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.19B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...